vimarsana.com
Home
Live Updates
Haystack Oncology Launches with $56 Million in Series A Fina
Haystack Oncology Launches with $56 Million in Series A Fina
Haystack Oncology Launches with $56 Million in Series A Financing to Accelerate Adoption of Post-Op Cancer Detection Technology and Optimize Cancer Therapy Monitoring and Treatment
/PRNewswire/ -- Haystack Oncology ("Haystack"), an oncology company that applies the next generation of circulating tumor DNA (ctDNA) detection technology to...
Related Keywords
Germany ,
New York ,
United States ,
Hamburg ,
Alexandria ,
Al Iskandariyah ,
Egypt ,
London ,
City Of ,
United Kingdom ,
American ,
Isaac Ro ,
Diamantis Xylas ,
Dan Edelstein ,
Joshua Cohen ,
George Petrocheilos ,
Bert Vogelstein ,
Nick Papadopoulos ,
Ken Kinzler ,
Jacob Vogelstein ,
Frank Holtrup ,
Johns Hopkins University ,
Detection Corp ,
Catalio Head Of Research ,
Johns Hopkins Kimmel Cancer Center ,
Ludwig Center ,
American Society Of Clinical Oncology ,
Catalio Capital ,
Catalio Capital Management ,
Exact Ventures ,
Exact Sciences ,
Alexandria Venture ,
American Society ,
Clinical Oncology ,
New England Journal ,
Haystack Duo ,
Thrive Earlier Detection Corp ,
Chief Financial Officer ,
Thrive Earlier Detection ,
Executive Chairman ,
Managing Partner ,
Capital Management ,
Guiding Adjuvant Therapy ,
Haystack Oncology ,